Dual‐targeting therapy against HER3/MET in human colorectal cancers

Dual‐targeting therapy against HER3/MET in human colorectal cancers

Abstract Background Colorectal cancer (CRC) is the most common malignancy in the world, and novel molecular targeted therapies for CRC have been vigorously pursued. We searched for novel combination therapies based on the expression patterns of membrane proteins in CRC cell lines. Results A positive...

Full description

Bibliographic Details
Main Authors: Akitaka Yamasaki, Rikuto Miyake, Yuta Hara, Hideki Okuno, Takuya Imaida, Kouki Okita, Shogo Okazaki, Yasutoshi Akiyama, Kenji Hirotani, Yuichi Endo, Kazue Masuko, Takashi Masuko, Yoshihisa Tomioka
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
colorectal cancer
Forkhead Box protein M1
human epidermal growth factor receptor family
mesenchymal to epithelial transition factor
Online Access:https://doi.org/10.1002/cam4.5673

Internet

https://doi.org/10.1002/cam4.5673

Similar Items